News
![For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKzBzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--65c4032d232766cf3f6e9dd909ab627da1102380/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230611134210_chart-aiq.jpg?locale=us)
For AI Exposure, Try Global Artificial Intelligence ETF
Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock
![For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKzBzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--65c4032d232766cf3f6e9dd909ab627da1102380/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230611134210_chart-aiq.jpg?locale=us)
For AI Exposure, Try Global Artificial Intelligence ETF
Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock
![For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKzBzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--65c4032d232766cf3f6e9dd909ab627da1102380/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230611134210_chart-aiq.jpg?locale=us)
For AI Exposure, Try Global Artificial Intelligence ETF
Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock
![For AI Exposure, Try Global Artificial Intelligence ETF: https://www.marketbeat.com/logos/articles/med_20230611134210_chart-aiq.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKzBzYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--65c4032d232766cf3f6e9dd909ab627da1102380/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230611134210_chart-aiq.jpg?locale=us)
For AI Exposure, Try Global Artificial Intelligence ETF
Unless you've been hiding under a rock, you should know about the artificial intelligence (AI) mania that has hooked mainstream attention. Numerous articles and videos talk about AI. The stock
![Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge: https://www.marketbeat.com/logos/articles/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNk1vYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ca8d90985ffcc38905d413f9f5f26e5a36a4f616/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg?locale=us)
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge
The story of Netflix Inc.'s (NASDAQ: NFLX) turnaround potential is getting investors' attention. The streamer's stock is up 23.71% in the past month, gapping up on May 18 following news that it
![Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge: https://www.marketbeat.com/logos/articles/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNk1vYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ca8d90985ffcc38905d413f9f5f26e5a36a4f616/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg?locale=us)
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge
The story of Netflix Inc.'s (NASDAQ: NFLX) turnaround potential is getting investors' attention. The streamer's stock is up 23.71% in the past month, gapping up on May 18 following news that it
![Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge: https://www.marketbeat.com/logos/articles/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNk1vYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--ca8d90985ffcc38905d413f9f5f26e5a36a4f616/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230607104258_netflix-collaboration-fuels-ias-doubleverify-stock.jpg?locale=us)
Netflix Collaboration Fuels IAS, DoubleVerify Stock Surge
The story of Netflix Inc.'s (NASDAQ: NFLX) turnaround potential is getting investors' attention. The streamer's stock is up 23.71% in the past month, gapping up on May 18 following news that it
![GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEluYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c990a7334279f6207ea8f4299db36fe7a42544ef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_EN_PRcom.001.jpeg?locale=us)
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry
IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce
![GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEluYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c990a7334279f6207ea8f4299db36fe7a42544ef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_EN_PRcom.001.jpeg?locale=us)
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry
IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce
![GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEluYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c990a7334279f6207ea8f4299db36fe7a42544ef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_EN_PRcom.001.jpeg?locale=us)
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry
IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce
![GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_EN_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEluYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c990a7334279f6207ea8f4299db36fe7a42544ef/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_EN_PRcom.001.jpeg?locale=us)
GeneTex Launches PD-L1 Antibody Comprehensively Validated by MS Validated Antibodies GmbH for Immunohistochemistry
IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce
![GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVuYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9fd891fae9fc8d9c5306e47500a84084182a72fa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_DE_PRcom.001.jpeg?locale=us)
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde
Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um
![GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVuYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9fd891fae9fc8d9c5306e47500a84084182a72fa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_DE_PRcom.001.jpeg?locale=us)
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde
Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um
![GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVuYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9fd891fae9fc8d9c5306e47500a84084182a72fa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_DE_PRcom.001.jpeg?locale=us)
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde
Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um
![GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde: https://www.irw-press.at/prcom/images/messages/2023/70848/GeneTexGlobal_DE_PRcom.001.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeEVuYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9fd891fae9fc8d9c5306e47500a84084182a72fa/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/GeneTexGlobal_DE_PRcom.001.jpeg?locale=us)
GeneTex lanciert PD-L1-Antikörper, der von MS Validated Antibodies GmbH für Immunhistochemie umfassend validiert wurde
Irvine, CA / Accesswire / 6. Juni 2023 / GeneTex, ein multinationales Unternehmen zur Antikörperherstellung, nutzt seine Produktionsplattform für rekombinante monoklonale Antikörper, um
![Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring: https://www.marketbeat.com/logos/articles/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOGttYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e1438db7c9ee2bf1ee5c5bf07038adb645ec452d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg?locale=us)
Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring
Dynatrace Inc. (NYSE: DT) has been a strong performer recently, benefiting from the market's optimism about the company’s AI technologies, as well as its network monitoring services.
A glimpse of
![Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring: https://www.marketbeat.com/logos/articles/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOGttYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e1438db7c9ee2bf1ee5c5bf07038adb645ec452d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230606065924_dynatrace-stock-surges-on-ai-mandatory-network-mon.jpg?locale=us)
Dynatrace Stock Surges On AI, 'Mandatory' Network Monitoring
Dynatrace Inc. (NYSE: DT) has been a strong performer recently, benefiting from the market's optimism about the company’s AI technologies, as well as its network monitoring services.
A glimpse of
![OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?: https://www.marketbeat.com/logos/articles/med_20230605102956_opec3.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXNsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9faa1e9a07d25812135098b73abe3f5a08972ec4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230605102956_opec3.png?locale=us)
OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?
In a surprising move, Saudi Arabia pledged to reduce its oil output by 1 million barrels per day for July at the June 4 OPEC meeting. This adjustment, which may continue monthly, places Saudi oil
![OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?: https://www.marketbeat.com/logos/articles/med_20230605102956_opec3.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXNsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9faa1e9a07d25812135098b73abe3f5a08972ec4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230605102956_opec3.png?locale=us)
OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?
In a surprising move, Saudi Arabia pledged to reduce its oil output by 1 million barrels per day for July at the June 4 OPEC meeting. This adjustment, which may continue monthly, places Saudi oil
![OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?: https://www.marketbeat.com/logos/articles/med_20230605102956_opec3.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXNsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9faa1e9a07d25812135098b73abe3f5a08972ec4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230605102956_opec3.png?locale=us)
OPEC Meeting: Is Saudi Arabia Trying to Squeeze the Oil Market?
In a surprising move, Saudi Arabia pledged to reduce its oil output by 1 million barrels per day for July at the June 4 OPEC meeting. This adjustment, which may continue monthly, places Saudi oil
![Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6570221dccb7f46bd1c166b0652e004ff86391e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230604121708_iwm-chart.jpg?locale=us)
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out
The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed
![Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6570221dccb7f46bd1c166b0652e004ff86391e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230604121708_iwm-chart.jpg?locale=us)
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out
The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed
![Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6570221dccb7f46bd1c166b0652e004ff86391e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230604121708_iwm-chart.jpg?locale=us)
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out
The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed
![Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out: https://www.marketbeat.com/logos/articles/med_20230604121708_iwm-chart.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemtsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6570221dccb7f46bd1c166b0652e004ff86391e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230604121708_iwm-chart.jpg?locale=us)
Risk-On In Small-Caps After iShares Russell 2000 ETF Breaks Out
The iShares Russell 2000 ETF (NYSE: IWM) has displayed relative weakness and lagged the overall market over the previous year. However, it notably broke that trend last week and finally showed
![Here’s Why Disney’s MCU is Sinking in Quicksand: https://www.marketbeat.com/logos/articles/med_20230604133550_chart-dis2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBellsYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a22a981df1b7daa4f4ed846a9bad0bc3f64f40c1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230604133550_chart-dis2.jpg?locale=us)
Here’s Why Disney’s MCU is Sinking in Quicksand
Media and entertainment giant The Walt Disney Company (NYSE: DIS) has seen a continued decline in its Disney+ subscribers and live-action box office debuts. Disney+ lost four million subscribers